Navigation Links
23andMe Names Andy Page to Board of Directors

MOUNTAIN VIEW, Calif., July 2, 2012 /PRNewswire/ -- 23andMe, a leading personal genetics company, has announced the addition of Andy Page to its Board of Directors.

"It is with great pleasure that we welcome Andy to our board," said Anne Wojcicki, CEO and co-founder of 23andMe. "Andy's strong finance and consumer background will be tremendously valuable as we grow the consumer genetic testing market."

Andy Page currently serves as the President of Gilt Groupe, an online luxury shopping destination, where he oversees the Company's various businesses including Women's, Men's, Kids & Baby, Home, Park & Bond, Gilt City and Gilt Taste. He joined Gilt in April 2010 as the Chief Financial Officer and transitioned to President in 2011.

Prior to joining Gilt, Andy was Chief Operating and Financial Officer at PlayPhone, Inc., where he was responsible for managing the company's multinational operations. Before PlayPhone, Andy was Chief Financial Officer and SVP of Business Strategy of StubHub Inc. There he managed the company's financial operations, business strategy, financial reporting, and administrative functions. He led the company's sale to eBay in 2007. Andy has also held senior executive positions at Panasas Inc., ONI Systems Corp., and Robertson Stephens & Company.

Andy holds a BA from Princeton University and a MBA from Harvard Business School. He is an advisor to several private e-commerce companies. He also serves on the board of directors of My New Red Shoes, a nonprofit organization that provides back-to-school clothes for homeless and low-income children in the San Francisco Bay Area.

About 23andMe
23andMe, Inc. is a leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service® enables individuals to gain deeper insights into their ancestry and inherited traits. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research. 23andMe, Inc., was founded in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. More information is available at


SOURCE 23andMe
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. 23andMe Presents Top Ten Most Interesting Genetic Findings of 2011
2. 23andMe Provides the Science Behind PBS Series "Finding Your Roots with Henry Louis Gates, Jr." With Its Personal Genome Service®
3. Khan Academy and 23andMe Partner to Promote Genetics Education on DNA Day
4. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
5. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
6. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
7. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
8. Codexis Names Wes Bolsen VP and Chief Marketing Officer
9. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
10. Fitzsimons Redevelopment Authority Names New President & CEO
11. Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President
Post Your Comments:
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading ... the Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio ... and clinical trial team. , Using the CONSULT module, patients and physicians can schedule ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
Breaking Biology Technology:
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
Breaking Biology News(10 mins):